Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:26 PM
Ignite Modification Date:
2025-12-24 @ 9:26 PM
NCT ID:
NCT00644332
Eligibility Criteria:
Inclusion Criteria:
* At least 3 months of documented history of stable angina or angina equivalents that is relieved by rest and/or sublingual NTG
* Taking antianginal therapy with beta-blockers, and/or dihydropyridine calcium antagonists, and/or long-acting nitrates for at least 4 weeks
* Mean angina frequency of ≥ 2 attacks per week
* Documented clinical evidence of ischemia
Exclusion Criteria:
* Clinically significant hepatic impairment
* Uncontrolled clinically significant cardiac arrhythmias or a history of ventricular fibrillation, torsades de points, or other life-threatening ventricular arrhythmias not associated with acute coronary syndrome
* Treatment with strong cytochrome P450 inhibitors including ketoconazole, itraconazole, clarithromycin, nefazodone, nelfinavir, ritonavir, indinavir, or saquinavir
* Prior treatment with ranolazine
* End-stage renal disease requiring dialysis
* Myocardial infarction or unstable angina
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00644332
Study Brief:
Protocol Section:
NCT00644332